| Product Code: ETC9937698 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Antimicrobial Resistance Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Antimicrobial Resistance Market - Industry Life Cycle |
3.4 United Kingdom (UK) Antimicrobial Resistance Market - Porter's Five Forces |
3.5 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 United Kingdom (UK) Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infections caused by antimicrobial-resistant bacteria |
4.2.2 Growing awareness and concern about the impact of antimicrobial resistance on public health |
4.2.3 Government initiatives and regulations to address antimicrobial resistance |
4.3 Market Restraints |
4.3.1 Limited availability of new effective antibiotics |
4.3.2 High cost associated with developing and bringing new antimicrobial drugs to market |
4.3.3 Lack of coordinated global efforts to combat antimicrobial resistance |
5 United Kingdom (UK) Antimicrobial Resistance Market Trends |
6 United Kingdom (UK) Antimicrobial Resistance Market, By Types |
6.1 United Kingdom (UK) Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 United Kingdom (UK) Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Antimicrobial Resistance Market Export to Major Countries |
7.2 United Kingdom (UK) Antimicrobial Resistance Market Imports from Major Countries |
8 United Kingdom (UK) Antimicrobial Resistance Market Key Performance Indicators |
8.1 Percentage of healthcare facilities implementing antimicrobial stewardship programs |
8.2 Number of new diagnostic tools and technologies for detecting antimicrobial resistance introduced to the market |
8.3 Rate of adoption of alternative therapies and strategies to reduce antimicrobial use |
9 United Kingdom (UK) Antimicrobial Resistance Market - Opportunity Assessment |
9.1 United Kingdom (UK) Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 United Kingdom (UK) Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 United Kingdom (UK) Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 United Kingdom (UK) Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 United Kingdom (UK) Antimicrobial Resistance Market - Competitive Landscape |
10.1 United Kingdom (UK) Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here